Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas AnalgesiaDermatologyMedical DeviceNeuroscienceOncology & HematologyPediatricsRare DiseaseOtherCOVID-19Cell & Gene TherapyWomen's HealthDiagnostics By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualitySafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Study Start-Up: Why You Really Need to Get This Right By Andrea Ochoa November 19, 2021 Clinical ResearchPhase 1 - Phase 4 Using the 505(b)(2) Pathway to Streamline Regulatory Approval for Combination Products By Ann Leonard October 26, 2021 Clinical ResearchPhase 1 - Phase 4 A Primer on Cancer Immunotherapy Part 2: The Cancer Immune Response & Mechanisms of Resistance By Ashley Herrick August 12, 2021 Clinical ResearchPhase 1 - Phase 4 A Primer on Cancer Immunotherapy Part 1: Goals & Major Approaches By Ashley Herrick August 10, 2021 Clinical ResearchPhase 1 - Phase 4 Introduction to CAR T-Cell Therapy Part 2: Additional Considerations & Future Opportunities By Ashley Herrick July 15, 2021 Clinical ResearchPhase 1 - Phase 4 Introduction to CAR T-Cell Therapy Part 1: Background & Current Development Landscape By Ashley Herrick July 13, 2021 Previous 1 2 3 4 … 43 Next × ALSO OF INTERESTNostalgia or Shell Shock? Assessing PTSD Is a...Designing Pediatric Analgesic Treatment...Gene Therapy 101: From the 1960s to Today
